Edition:
India

Convelo Therapeutics To Acquire Genentech To Discover Novel Remyelinating Therapies


Tuesday, 16 Jul 2019 

July 16 (Reuters) - Roche Holding AG ::CONVELO THERAPEUTICS ENTERS INTO COLLABORATION AND OPTION TO ACQUIRE AGREEMENT WITH GENENTECH TO DISCOVER NOVEL REMYELINATING THERAPIES.CONVELO THERAPEUTICS - CONVELO WILL RECEIVE AN UNDISCLOSED UPFRONT PAYMENT AND RESEARCH SUPPORT FROM GENENTECH..CONVELO THERAPEUTICS - CONVELO AND GENENTECH WILL COLLABORATE TO DISCOVER NOVEL REMYELINATION THERAPIES FOR MS AND OTHER MYELIN DISORDERS.CONVELO - GENENTECH RETAINS EXCLUSIVE OPTION TO ACQUIRE OUTSTANDING STOCK OF CONVELO FOR ADDITIONAL UNDISCLOSED PAYMENT & DOWNSTREAM MILESTONES..